Back to mobile site

Leerink Swann Downgrades Salix Pharmaceuticals (SLXP) to Market Perform

February 23, 2015 7:21 AM EST Send to a Friend
Leerink Swann downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login